Another study found that patients with type 2 diabetes and kidney disease who were prescribed GLP-1s had a 39% higher risk of requiring kidney replacement therapy (dialysis or transplant), compared to patients taking SGLT2 inhibitors
Learn more about our approach to content integrity
Referencias Emma Simonsen MD , Lars Christian Lund PhD , Martin Thomsen Ernst MSc , Vidar Hjellvik PhD , Laszlo Hegeds DMSc , Steffen Hamann PhD , ystein Kalsnes Jrstad PhD , et al
Patients who communicate early about side effects are often easier to support than patients who wait until nausea, constipation, fatigue, or poor intake has already disrupted treatment
This hormone: Signals your brain that youre full and satisfied Tells your pancreas to release insulin to manage blood sugar Slows down how quickly food leaves your stomach Reduces appetite and food cravings Helps prevent your liver from releasing excess glucose The Problem: Natural GLP-1 only lasts a few minutes before enzymes break it down
Dietary protein, weight loss, and weight maintenance